Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0HG8 stock hub

LON/0HG8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HG8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

60.3B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HG8

In the news

Latest news · LON/0HG8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 12.9P50 16.9P75 23.5

Trailing P/E15.2

P25 15.9P50 22.9P75 35.8

ROE12.1

P25 -54.2P50 2.1P75 13.7

ROIC8.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HG8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	96,615
Employees Change	-7,100%
Employees Change Percent	-6.81
Enterprise value	$76.6B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US0367521038
Last refreshed	2026-05-10
Market cap	$60.3B
Price	$376
Price currency	USD
Rev Per Employee	1,570,936.59x
Sector	Healthcare
Sic	6324
Symbol	lon/0HG8
Website	https://www.elevancehealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.59%
EV Earnings	19.3x
EV/EBIT	13.36x
EV/EBITDA	12.02x
EV/FCF	15.69x
EV/Sales	0.52x
FCF yield	8.11%
Forward P/E	14.59x
P/B ratio	1.81x
P/E ratio	15.18x
P/S ratio	0.4x
PE Ratio10 Y	16.44x
PE Ratio3 Y	16.31x
PE Ratio5 Y	17.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.9%
EBITDA Margin	4.26%
FCF margin	3.22%
Gross margin	25.89%
Gross Profit	$39.3B
Net Income	$4B
Net Income Growth	-11.39%
Net Income Growth Q	-19.19%
Net Income Growth Years	0%
Net Income Growth3 Y	-4.89%
Net Income Growth5 Y	2.15%
Pretax Margin	3.1%
Profit Margin	2.62%
Profit Per Employee	$41,097
Profitable Years	14
ROA	3.98
Roa5y	5.41
ROCE	9.71
ROE	12.09
Roe5y	15.57
ROIC	8.63
Roic5y	11.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-7.87%
Cagr3y	-5.45%
Cagr5y	0.44%
Div CAGR3	4.79%
Div CAGR5	11.19%
EPS Growth	-8.15
EPS Growth Q	-16.75
EPS Growth Years	0
EPS Growth3 Y	-2.31
EPS Growth5 Y	4.7
FCF Growth	75.56%
FCF Growth Q	399.03%
FCF Growth3 Y	-16.62%
FCF Growth5 Y	-7.75%
OCF Growth	56.9%
OCF Growth Q	325.96%
OCF Growth10 Y	7.11%
OCF Growth3 Y	-14.87%
OCF Growth5 Y	-6.56%
Revenue Growth	9.44x
Revenue Growth Q	2.64x
Revenue Growth Quarters	7x
Revenue Growth Years	13x
Revenue Growth3 Y	7.64x
Revenue Growth5 Y	9.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.63
Assets	$95.3B
Cash	$28.1B
Debt	$24.1B
Debt EBITDA	$3.67
Debt Equity	$0.72
Debt FCF	$4.94
Equity	$33.4B
Interest Coverage	5.52
Liabilities	$61.9B
Net Cash	$-16.8B
Net Cash By Market Cap	$-27.88
Net Debt EBITDA	$2.6
Net Debt Equity	$0.5
Net Debt FCF	$3.44
Tangible Book Value	$3.4B
Tangible Book Value Per Share	$15.57
WACC	6.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.48
Net Working Capital	$10B
Quick ratio	1.33
Working Capital	$16.5B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.57%
Dividend Growth	-0.84%
Dividend Growth Years	8%
Dividend per share	$5.09
Dividend Years	9
Dividend Yield	1.35%
Ex Div Date	2026-03-10
Last Dividend	$1.28
Payout Frequency	Quarterly
Payout Ratio	28.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-7.87%
200-day SMA	326.9
3Y total return	-15.49%
50-day SMA	316.6
50-day SMA vs 200-day SMA	50under200
5Y total return	2.22%
All Time High	567.4
All Time High Change	-33.75%
All Time High Date	2024-09-03
All Time Low	200.1
All Time Low Change	87.84%
All Time Low Date	2020-04-03
ATR	15.45
Beta	0.67
Ch YTD	6.99
High	378
High52	422.5
High52 Date	2025-05-12
High52ch	-11.04%
Low	362.9
Low52	273.5
Low52 Date	2025-07-25
Low52ch	37.43%
Ma50ch	18.74%
Price vs 200-day SMA	14.99%
RSI	77.52
RSI Monthly	48.97
RSI Weekly	61.56
Sharpe ratio	-0.11x
Sortino ratio	-0.01
Total Return	4.92%
Tr YTD	7.66
Tr1m	20.34%
Tr1w	0.81%
Tr3m	11.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$5.9B
Operating margin	3.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	216,661,597%
Net Borrowing	1,350,399,274
Shares Insiders	0.12%
Shares Institutions	96.58%
Shares Qo Q	-0.63%
Shares Yo Y	-3.57%
Short Ratio	2.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$4.7B
Average Volume	631.65x
Bv Per Share	153
CAPEX	$-874.7M
Ch1m	20.34
Ch1w	0.81
Ch1y	-9.79
Ch3m	11.02
Ch3y	-19.47
Ch5y	-4.74
Ch6m	20.14
Change	0.67%
Change From Open	0.79
Close	373.4
Days Gap	-0.12
Dollar Volume	22,928.1
Earnings Date	2026-04-22
EBIT	$5.9B
EBITDA	$6.5B
EPS	$17.81
F Score	6
FCF	$4.9B
FCF EV Yield	6.37x
Financing CF	-1,775,122,920
Fiscal Year End	December
Founded	2,001
Goodwill	20,787,786,760
Graham Number	340.51898
Graham Upside	-9.41
Income Tax	$742.2M
Investing CF	-2,339,315,145
Is Primary Listing	0
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Lynch Fair Value	$124
Lynch Upside	-67.05
Ma150	334.3
Ma150ch	12.42%
Ma20	347
Ma20ch	8.31%
Net CF	1,633,506,885
Next Earnings Date	2026-07-15
Open	372.9
P FCF Ratio	12.34
P OCF Ratio	10.46
Payment Date	2026-03-25
Position In Range	85.94
Ppne	3,415,974,698
Price Date	2026-05-08
Price EBITDA	$9.32
Ptbv Ratio	17.8
Relative Volume	0.1x
Revenue	151,776,038,880x
SBC By Revenue	0.12x
Share Based Comp	189,326,250
Tax By Revenue	0.49x
Tax Rate	15.76%
Tr6m	21.51%
Volume	61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0HG8 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$5.09 annual per share

Payout ratio

+29.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.2%

8 consecutive years of growth

Total shareholder yield

+4.9%

Next ex-dividend date: 2026-03-10

Performance

LON/0HG8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HG8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+96.6%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HG8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

77.5

Above 70: short-term overbought

Price vs 200-day MA

+15.0%

50/200-day relationship not available

Beta (5Y)

0.67

Less volatile than the market

Sharpe ratio

-0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HG8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HG8 stock rating?

lon/0HG8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HG8 analysis?

The full report lives at /stocks/lon/0HG8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HG8?

The latest report frames lon/0HG8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HG8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.